HIV prevention trial design in an era of effective pre-exposure prophylaxis.
| dc.contributor.author | Cutrell, Amy. | |
| dc.contributor.author | Donnell, Deborah. | |
| dc.contributor.author | Dunn, David T. | |
| dc.contributor.author | Glidden, David V. | |
| dc.contributor.author | Grobler, Anna Christina. | |
| dc.contributor.author | Hanscom, Brett. | |
| dc.contributor.author | Stancil, Britt S. | |
| dc.contributor.author | Meyer, Daniel R. | |
| dc.contributor.author | Wang, Ronnie. | |
| dc.contributor.author | Cuffe, Robert L. | |
| dc.date.accessioned | 2018-03-18T18:46:02Z | |
| dc.date.available | 2018-03-18T18:46:02Z | |
| dc.date.created | 2017 | |
| dc.date.issued | 2017 | |
| dc.description | CAPRISA, 2017. | en_US |
| dc.description.abstract | Abstract available in pdf. | en_US |
| dc.identifier.citation | Cutrell, A., Donnell, D., Dunn, D.T., Glidden, D.V., Grobler, A., Hanscom, B., Stancil, B.S., Meyer, R.D., Wang, R. and Cuffe, R.L. 2017. HIV prevention trial design in an era of effective pre-exposure prophylaxis. HIV clinical trials 18(5-6), 177-188. | en_US |
| dc.identifier.uri | http://hdl.handle.net/10413/15098 | |
| dc.language.iso | en | en_US |
| dc.publisher | American Association for the Advancement of Science. | en_US |
| dc.subject | HIV-1. | en_US |
| dc.subject | Pre-exposure prophylaxis (PrEP) | en_US |
| dc.subject | TDF/FTC. | en_US |
| dc.subject | Non-inferiority trials. | en_US |
| dc.subject | Tenofovir disoproxil fumarate/emtricitabine. | en_US |
| dc.title | HIV prevention trial design in an era of effective pre-exposure prophylaxis. | en_US |
| dc.type | Peer reviewed journal article | en_US |